ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - July 1959

Decade

Year

Issue

November 2020, Vol 77, No. 11, Pages 1329-1453

Viewpoint

Stroking Out While Black—The Complex Role of Racism

Abstract Full Text
JAMA Neurol. 2020;77(11):1343-1344. doi:10.1001/jamaneurol.2020.3510

This Viewpoint highlights the complex role of racism in stroke, and suggests a framework for understanding its effects.

Time for a New Image of Parkinson Disease

Abstract Full Text
JAMA Neurol. 2020;77(11):1345-1346. doi:10.1001/jamaneurol.2020.2412

This Viewpoint discusses an updated image of Parkinson disease that more accurately reflects the heterogeneity in age at onset, sex, race/ethnicity, and disease experience.

Is There a Right to Delay Determination of Death by Neurologic Criteria?

Abstract Full Text
JAMA Neurol. 2020;77(11):1347-1348. doi:10.1001/jamaneurol.2020.1815

The Viewpoint discusses the controversy about whether families should have the right to delay apnea testing to determine death by neurologic critera.

On the Brain

Medical Aid in Living

Abstract Full Text
JAMA Neurol. 2020;77(11):1349-1350. doi:10.1001/jamaneurol.2020.2915

This article describes a patient’s experience choosing medical aid in dying after living with an untreatable terminal illness.

Editorial

Intensive Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Extreme Initial Hypertension: Primum Non Nocere

Abstract Full Text
JAMA Neurol. 2020;77(11):1351-1352. doi:10.1001/jamaneurol.2020.3081

Standardizing Brain Death Globally

Abstract Full Text
JAMA Neurol. 2020;77(11):1353-1354. doi:10.1001/jamaneurol.2020.1243
Original Investigation

Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial

Abstract Full Text
free access has audio
JAMA Neurol. 2020;77(11):1355-1365. doi:10.1001/jamaneurol.2020.3075

This secondary analysis of a randomized clinical trial evaluates the differential outcomes of intensive vs standard systolic blood pressure reduction in patients with intracerebral hemorrhage and initial systolic blood pressure of 220 mm Hg or more vs less than 220 mm Hg.

Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1366-1372. doi:10.1001/jamaneurol.2020.2730

This cohort study compares the rate of ischemic stroke among patients with COVID-19 vs patients with influenza in 2 hospitals in New York City, New York.

Association of Delirium With Long-term Cognitive Decline: A Meta-analysis

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1373-1381. doi:10.1001/jamaneurol.2020.2273

This meta-analysis seeks to determine if an episode of delirium is an independent risk factor for long-term cognitive decline.

Trends in Antihypertensive Medication Use Among Individuals With a History of Stroke and Hypertension, 2005 to 2016

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1382-1389. doi:10.1001/jamaneurol.2020.2499

This cross-sectional study investigates the adequacy of blood pressure control among stroke survivors and antihypertensive treatment trends using National Health and Nutrition Examination Survey data.

A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1390-1397. doi:10.1001/jamaneurol.2020.2349

This meta-analysis evaluates which factors are associated with diffusion-weighted imaging lesions and whether these lesions are associated with functional outcomes among patients with intracerebral hemorrhage.

Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1398-1407. doi:10.1001/jamaneurol.2020.2453

This cohort study uses data from the MSBase international registry to examine the association of demographic and clinical factors, including the presence of relapses and exposure to immunotherapy, with the rate of disability accumulation in patients with secondary progressive multiple sclerosis.

Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy

Abstract Full Text
open access
JAMA Neurol. 2020;77(11):1408-1419. doi:10.1001/jamaneurol.2020.2526

This cross-sectional study investigates the potential of novel tau radiotracer 18F-PI-2620 as a biomarker in patients with clinically diagnosed progressive supranuclear palsy.

Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis

Abstract Full Text
free access has multimedia
JAMA Neurol. 2020;77(11):1420-1429. doi:10.1001/jamaneurol.2020.2231

This study describes expanding neurologic phenotype, cancer associations, outcomes, and immunopathologic features of Kelch-like protein-11 encephalitis.

Hypoxic-Ischemic Encephalopathy Evaluated by Brain Autopsy and Neuroprognostication After Cardiac Arrest

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1430-1439. doi:10.1001/jamaneurol.2020.2340

This cohort study compares the parameters used for prognosis after cardiac arrest with the severity of hypoxic-ischemic encephalopathy shown on autopsy.

Brief Report

Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1440-1445. doi:10.1001/jamaneurol.2020.2687

This case series presents the clinical findings of 4 children who experienced neurological manifestations of coronavirus disease 2019.

Images in Neurology

Longitudinally Extensive Spinal Cord Lesion in Erdheim-Chester Disease

Abstract Full Text
JAMA Neurol. 2020;77(11):1446-1447. doi:10.1001/jamaneurol.2020.2460

This case report describes a 67-year-old man with 4 years of progressive quadriparesis and dysarthria, progressive right more than left lower limb weakness, and difficulty walking.

Lost Dopaminergic Bindings in the Caudate of a Patient With Frontotemporal Lobar Degeneration–Motor Neuron Disease

Abstract Full Text
JAMA Neurol. 2020;77(11):1448-1449. doi:10.1001/jamaneurol.2020.2786

This case report describes a woman whose diagnosis of frontotemporal lobar degeneration–motor neuron disease involved evidence on positron emission tomography of dopaminergic damage to the caudate.

Comment & Response

Palliative Care in Parkinson Disease—Is It Beneficial for All?

Abstract Full Text
JAMA Neurol. 2020;77(11):1450. doi:10.1001/jamaneurol.2020.3212

Palliative Care in Parkinson Disease—Is It Beneficial for All?—Reply

Abstract Full Text
JAMA Neurol. 2020;77(11):1450-1451. doi:10.1001/jamaneurol.2020.3215

Remote Ischemic Perconditioning for the Treatment of Acute Ischemic Stroke

Abstract Full Text
JAMA Neurol. 2020;77(11):1451-1452. doi:10.1001/jamaneurol.2020.3555

Remote Ischemic Perconditioning for the Treatment of Acute Ischemic Stroke—Reply

Abstract Full Text
JAMA Neurol. 2020;77(11):1452. doi:10.1001/jamaneurol.2020.3562
Correction

Error in Author Degrees and Reference List

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1452. doi:10.1001/jamaneurol.2020.3284

Error in Figure

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1453. doi:10.1001/jamaneurol.2020.3037

Errors in Figures and Reference List

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1453. doi:10.1001/jamaneurol.2020.3470

Errors in Figure

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1453. doi:10.1001/jamaneurol.2020.3416
JAMA Neurology Masthead

JAMA Neurology

Abstract Full Text
free access
JAMA Neurol. 2020;77(11):1329. doi:10.1001/jamaneurol.2019.3229
×